Inspectorate warns of stolen insulin pens
The medicines may be offered as slimming medication through illegal channels.
Listen to this article
There is no audio version yet. Request one and an AI voice will read the article aloud.
Read by an AI voice.
The Health and Youth Care Inspectorate has warned European authorities about medicines stolen from a Dutch wholesaler. They are mainly insulin pens that may be sold online as slimming medication.
The warning dates from Tuesday 20 October. According to the inspectorate, the stolen medicines may be offered through illegal online shops, social media or other informal channels. The inspectorate warns that using illegally obtained medicines is potentially life-threatening.
Novo Nordisk previously reported that a large consignment of insulin pens had been stolen from a Dutch medicines wholesaler. The manufacturer warned that some pens might be sold as if they were weight-loss medicines. In reality, they contain insulin, not semaglutide, the active substance in Wegovy, among other medicines.
Insulin lowers blood sugar levels. In people who do not need it, this can lead to dangerously low blood sugar and loss of consciousness. The inspectorate calls the use of illegally obtained medicines potentially life-threatening, but does not report that all the stolen pens are counterfeit or have already reached consumers.
The inspectorate has not given a number of stolen pens. NL Times reported, based on information from Novo Nordisk, that thousands of insulin pens were involved. Police and the companies concerned are investigating the theft; nothing has been reported about arrests or specific sales addresses.
The IGJ is urging consumers and healthcare providers to be extra alert to medicines offered outside recognised pharmacies. Anyone who has bought medication online through an unrecognised channel should, according to the inspectorate, not use it and should contact a doctor or pharmacy.
The warning is also aimed at people seeking slimming medication: according to the inspectorate, the stolen insulin pens may be offered as slimming products.
Also show where in Europe and in the world
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The article's central points are confirmed by the IGJ and the manufacturer, with independent reporting on the theft. The scale and possible distribution are explicitly presented as uncertain.
- confirmed The IGJ warned European authorities on 20 October 2026 about medicines stolen from a Dutch wholesaler. — This is stated in the IGJ news report. source
- confirmed They are mainly insulin pens that may be sold as slimming medication. — The IGJ and Novo Nordisk explicitly mention this risk. source
- confirmed The stolen pens contain insulin and not semaglutide. — This was reported by NL Times based on information from Novo Nordisk. source
- confirmed Using insulin when it is not needed can lead to dangerously low blood sugar and loss of consciousness. — This health risk is described by Novo Nordisk and the IGJ. source
- confirmed The scale of the theft has not been made public; NL Times referred to thousands of pens. — The IGJ gives no figure; NL Times mentions thousands based on Novo Nordisk. source
- confirmed Police and the companies concerned are investigating the theft. — NL Times reports that the police are investigating; Novo Nordisk says it is working with the authorities. source
Editor's note
It is certain that a consignment of medicines was stolen from a Dutch wholesaler and that the IGJ warned European authorities on 20 October. The precise scale, distribution and any sale to consumers are unknown; the figures come from Novo Nordisk and reporting based on it.Sources
- IGJ waarschuwt Europese autoriteiten voor gestolen medicijnen — Inspectie Gezondheidszorg en Jeugd
- Thousands of Novo Nordisk insulin pens stolen from Dutch wholesaler — NL Times
- Media Alert - De veiligheid van patiënten staat voor ons altijd voorop — Novo Nordisk
More on this in Dutch media
- AD — „insuline geneesmiddelen”
- de Volkskrant — „insuline geneesmiddelen”
- RTL Nieuws — „insuline geneesmiddelen”